TheEdgeResearch
Home / Stocks / OCPNF

Olympus Corporation (OCPNF)

OTC Healthcare Medical - Devices
$11.53 ▲ +0.00%
Market Cap
$12.70B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.20
52-Wk Range
8-14
CEO
Robert White
Country
JP
Currency
USD

Olympus Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Hachioji, TY, JP. The stock last traded at $11.53, up 0.00% on the session, giving a market capitalisation of $12.70B. On trailing twelve-month figures it carries a trailing P/E of 21.78, a net margin of 8.5%. Its beta of 0.20 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
21.78
Price / Sales
1.83
Price / Book
2.58
EV / EBITDA
10.61
Gross margin
66.2%
Operating margin
17.8%
Net margin
8.5%
Return on equity
—
Debt / equity
0.45
Current ratio
1.67
Dividend yield
3.3%
Payout ratio
36.2%
Company profile
Exchange
Other OTC
Employees
28,138
IPO date
2010-01-13
Headquarters
Hachioji, TY, JP
About Olympus Corporation

Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.

Comparable companies

Olympus Corporation is most often compared with the following Healthcare names:

BDXGEHCISRGMDTSYK
More research on OCPNF
OCPNF technical analysis OCPNF TheEdge Score Compare against peers
Open full interactive analysis & DCF →